ArticleFrontiers in pharmacology2021

Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study.

Yiting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.